Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02030483
Title Palbociclib in Combination With Lenalidomide and Dexamethasone for Multiple Myeloma
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Weill Medical College of Cornell University
Indications

multiple myeloma

Therapies

Palbociclib

Dexamethasone

Lenalidomide

Age Groups: adult
Covered Countries USA

Additional content available in CKB BOOST